Clinical Trial: Time-Restricted Eating in Huntington's Disease: A Clinical Pilot Study
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Huntington Disease
Study Type: INTERVENTIONAL
Official Title: Safety, Feasibility, and Biomarker Effects of Time-restricted Eating for 12 Weeks in Early-stage Huntington's Disease.
Brief Summary:
This trial examines whether 12 weeks of time-restricted eating (TRE), otherwise known as intermittent fasting, appears safe and feasible in persons with early-stage Huntington's disease (HD).The study also explores the effects of TRE on biomarkers and clinical measures associated with HD progression.
Read more